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AbstrACt 
Objective This study assesses the impact of obesity on 
life expectancy for 26 European national populations and 
the USA over the 1975–2012 period.
Design Secondary analysis of population-level obesity 
and mortality data.
setting European countries, namely Austria, Belarus, 
Belgium, the Czech Republic, Denmark, Estonia, Finland, 
France, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, 
Luxembourg, the Netherlands, Norway, Poland, Portugal, 
the Russian Federation, Slovakia, Spain, Sweden, 
Switzerland, Ukraine and the UK; and the USA.
Participants National populations aged 18–100 years, 
by sex.
Measurements Using data by age and sex, we calculated 
obesity-attributable mortality by multiplying all-cause 
mortality (Human Mortality Database) with obesity-
attributable mortality fractions (OAMFs). OAMFs were 
obtained by applying the weighted sum method to obesity 
prevalence data (non-communicable diseases (NCD) Risk 
Factor Collaboration) and European relative risks (Dynamic 
Modeling for Health Impact Assessment (DYNAMO- HIA)). We 
estimated potential gains in life expectancy (PGLE) at birth 
by eliminating obesity-attributable mortality from all-cause 
mortality using associated single-decrement life tables.
results In the 26 European countries in 2012, PGLE due 
to obesity ranged from 0.86 to 1.67 years among men, and 
from 0.66 to 1.54 years among women. In all countries, 
PGLE increased over time, with an average annual 
increase of 2.68% among men and 1.33% among women. 
Among women in Denmark, Switzerland, and Central and 
Eastern European countries, the increase in PGLE levelled 
off after 1995. Without obesity, the average increase in 
life expectancy between 1975 and 2012 would have been 
0.78 years higher among men and 0.30 years higher 
among women.
Conclusions Obesity was proven to have an impact on 
both life expectancy levels and trends in Europe. The 
differences found in this impact between countries and 
the sexes can be linked to contextual factors, as well as 
to differences in people’s ability and capacity to adopt 
healthier lifestyles.
IntrODuCtIOn
Obesity is a global epidemic,1 with Europe 
currently ranking second worldwide after 
the USA.2 Over the last 20 years obesity prev-
alence has increased threefold in Europe,3 
although not uniformly across countries.4 
Estimates for 2014 indicate that obesity varied 
threefold across European countries, ranging 
from a low of 9% in Romania to a high of 
26% in Malta.5 Obesity constitutes a serious 
health burden at the individual and popu-
lation levels because it is associated with an 
increased risk of morbidity6 and mortality.7 
However, the potential impact of the increase 
in obesity on life expectancy trends remains 
largely unknown.8 
The few existing studies that assessed the 
impact of obesity on life expectancy at the 
population level provided estimates at one 
specific point in time only.9 10 Olshansky 
et al9 found that if obesity was eliminated, life 
expectancy at birth (e0) in the USA in 2000 
would be 0.21–1.08 years higher, depending 
on gender and ethnicity. Preston et al10 esti-
mated for 16 low-mortality countries in 2006 
that the reduction in life expectancy at age 50 
(e50) due to obesity was greatest in the USA, 
at more than 1.5 years, and ranged from 0.50 
to 1.19 years for women and from 0.72 to 1.37 
years for men in European countries.
strengths and limitations of this study
 ► This is the first study to assess the impact of obesity 
on life expectancy at birth over time, and we do so 
here for 26 European countries and the USA.
 ► We used recent long-term comparable data on obe-
sity prevalence based on population-based mea-
surement studies, and European relative risks of 
dying from obesity by age and sex from a recent 
meta-analysis.
 ► Because of remaining data limitations regarding 
prevalence and relative risks, we had to use a fairly 
simple—although commonly applied—methodolo-
gy to estimate obesity-attributable mortality.
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Gaining insight into the impact of obesity on trends in 
life expectancy is especially relevant11 given the marked 
differences in life expectancy trends across Europe.12 
In Western European countries, e0 has been increasing 
steadily, and has risen 6–8 years since 1970. But in Central 
and Eastern Europe (CEE), e0 stagnated or even declined 
between the 1970s and the 1980s, and did not start 
increasing again until the 1990s. There are also marked 
differences in e0 trends between individual European 
countries.12
In light of these important differences between Euro-
pean countries in both obesity prevalence and life expec-
tancy over time, our aim is to assess the impact of obesity 
on long-term trends in life expectancy across a wide range 
of European countries.
Our sole focus is on the impact of obesity, given the 
significant health burden caused by obesity, the large 
body of literature on its impact and the well-documented 
association of obesity with mortality.
DAtA AnD MethODs
setting
We studied the impact of obesity on life expectancy by 
sex over the 1975–2012 period in 26 European countries: 
Austria, Belarus, Belgium, the Czech Republic, Denmark, 
Estonia, Finland, France, Hungary, Iceland, Ireland, Italy, 
Latvia, Lithuania, Luxembourg, the Netherlands, Norway, 
Poland, Portugal, the Russian Federation, Slovakia, Spain, 
Sweden, Switzerland, Ukraine and the UK; and the USA 
as a comparison country.10
Data
Long-term comparable obesity prevalence data (body 
mass index (BMI) ≥30 kg/m2) by country, sex, age (18–19, 
20–24, …, 85+) and year (1975–2012), based on 1698 
population-based measurement studies, were obtained 
from the non-communicable diseases (NCD) Risk Factor 
Collaboration study.13 These validated data comprise the 
available measured height and weight data of 19.2 million 
participants from representative data sources, supple-
mented with estimates based on information from other 
years and related countries from a Bayesian hierarchical 
model.13 The same model was applied to all countries and 
used as an input in the measured weight and height data, 
including covariates that help predict BMI.13
The age-specific (<50, 50–59, 60–69 and ≥70 years) 
and sex-specific relative risks (RRs) of dying from obesity 
(see online supplementary table S1) came from a review 
of studies mainly conducted in Western Europe and the 
USA, with the normal-weight category used as the refer-
ence group (18.5≥BMI≤25 kg/m2).14 These age-specific 
and sex-specific RRs were largely in line with the overall 
European RR of 1.64 recently estimated by the Global 
BMI Mortality Collaboration.7 The differences across 
age groups found in that study were similar with those 
reported in our findings (ie, higher RRs at younger 
than at older ages), although they were less distinct.7 In 
addition, the use of RRs with the normal-weight category 
as the reference category is in line with previous studies 
that estimated obesity-attributable mortality,15–19 while 
the estimation of obesity-attributable mortality with such 
an RR can be considered the theoretically maximally 
possible attributable mortality.20
All-cause mortality numbers and exposure population 
data by single year of age, sex, year and country were 
obtained from the Human Mortality Database.21 These 
data are of high quality and are widely used within the 
demographic community and beyond.22
Patient and public involvement
No patients were involved in this study.
MethODs
We performed our analyses separately by country and 
sex, based on data by single year of age (18–100). The 
obesity prevalence data were turned into single-age prev-
alence (18–100) by applying Loess smoothing.23 The RRs 
were turned into single-year RRs (18–100) using linear 
regression.
To estimate the obesity-attributable mortality fraction 
(OAMF)—that is, the share of all-cause mortality due to 
obesity—we used the Rockhill formula to estimate OAMFs 
by age (a) and sex (s).24
 
 
OAMFa,s =
Pa,s ·
(
RRa,s−1
)
1+
(
Pa,s·
(
RRa,s−1
)) (Equation 1)
 
 
where P is the obesity prevalence. We then weighted the 
OAMFa,s with the corresponding number of deaths.
For the estimation of the impact of obesity on life expec-
tancy, we needed age-specific and sex-specific (non-)
obesity-attributable mortality rates. These were obtained 
by multiplying OAMFa,s and [1− OAMFa,s], respectively, 
with age-specific and sex-specific all-cause mortality rates.
To ensure comparability across countries, over time, 
and between men and women, we applied direct age and 
sex standardisation25 to obesity prevalence, OAMFs and 
obesity-attributable mortality rates, using the European 
population of 201126 as the standard.
To assess the impact of adult obesity on e0, we calculated 
for each country the potential gain in life expectancy 
(PGLE) if obesity-attributable mortality was eliminated, 
by calendar year and sex, and is in line with the approach 
by Preston et al.10 First, we calculated e0 by applying 
standard life table techniques to age-specific all-cause 
mortality rates (0–100)25). Second, we applied associated 
single-decrement life tables (ASDLT)25) to age-specific 
and sex-specific non-obesity-attributable mortality rates 
(0–100) to obtain e0 if obesity-attributable mortality was 
eliminated. The PGLE represents the difference between 
the e0 based on the ASDLT and the original e0.
To summarise the changes in PGLE across countries, 
we estimated the average annual changes in PGLE (in %):
  Average annual changes in PGLE
(
%
)
=
∑2012
t=1976
(
PGLEt− PGLEt−1
)
PGLEt−1
2012−1975 100  
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To assess the impact of obesity on time trends in e0 
between 1975 and 2012, we subtracted the observed 
change in e0 from the change in e0 without obesity. The 
change in e0 without obesity was obtained by using the 
e0 values from the ASDLT applied to non-obesity-attribut-
able mortality for 1975 and 2012.
results
For the 26 European countries, the age-standardised 
OAMF was, on average, 11% among men and 10% 
among women in 2012. For the USA, these estimates 
were substantially higher, that is, 15% and 14%, respec-
tively. The average OAMF levels were higher in Northern, 
Western and Southern Europe combined (hereafter, 
Western Europe) than in CEE among men, while the 
opposite was the case among women.
OAMFs were increasing over time for all countries and 
both sexes, although not to the same extent (see figure 1, 
online supplementary figure S1). In Western Europe, 
OAMFs generally increased over the 1975–2012 period, 
and at a faster pace among men. In CEE, by contrast, 
OAMFs clearly stagnated, and even declined between 
1990 and 2000. The overall increase in OAMFs was 
greatest in the USA, Ireland, Norway (men) and the UK 
(women).
In the 26 European countries in 2012, estimates of 
PGLE at birth if obesity was eliminated ranged from 0.86 
to 1.67 years among men (1.22 on average) and from 0.66 
to 1.54 years among women (0.98 on average)  figure 2, 
online supplementary figure S2 and table S2). Among 
men in the USA, the PGLE estimate was, at 1.73 years, 
slightly higher than the highest estimate in Europe; 
and among women in the USA, the PGLE estimate was, 
at 1.44 years, the second highest after the estimate for 
Russia. The average PGLE estimate was 1.08 among men 
and 0.86 among women in Western Europe, and was 1.44 
among men and 1.16 among women in CEE (see online 
supplementary table S2).
Overall, from 1975 to 2012, PGLE due to obesity 
increased in all of the countries (figures 2–4, online 
supplementary figure S2). The increase was greater 
among men (average annual increase of 2.68%) than 
among women (average annual increase of 1.33%), was 
largest among men in Portugal and Belarus and among 
women in Portugal, and was substantial among men and 
women in Norway (figures 3 and 4). While there was a 
general increase in PGLE due to obesity, this trend stag-
nated among women in CEE from around 1990 onwards, 
and levelled off after 1995 among women in Denmark 
and Switzerland.
Figure 1 Age-standardised obesity-attributable mortality 
fractions in 26 European countries* (by five regions) and 
the USA, 1975–2014, 18–100 years. *Countries within the 
same region are presented with the same colour. Central 
Europe: the Czech Republic, Hungary, Poland and Slovakia; 
Eastern Europe: Belarus, Estonia, Ukraine, Latvia, Lithuania 
and the Russian Federation; Northern Europe: Denmark, 
Finland, Iceland, Norway and Sweden; Southern Europe: 
Italy, Portugal and Spain; Western Europe: Austria, Belgium, 
France, Ireland, Luxembourg, the Netherlands, Switzerland 
and the UK.
Figure 2 Potential gains in life expectancy at birth if 
obesity-attributable mortality was eliminated, in 26 European 
countries* (differentiating Western and Central Eastern 
Europe) and the USA, 1975–2012. *Countries within the same 
region are presented with the same colour. Central Eastern 
Europe: Belarus, the Czech Republic, Estonia, Hungary, 
Latvia, Lithuania, Poland, the Russian Federation, Slovakia 
and Ukraine; Western Europe: Austria, Belgium, Denmark, 
Finland, France, Iceland, Ireland, Italy, Luxembourg, 
the Netherlands, Norway, Portugal, Spain, Sweden, 
Switzerland and the UK.
Figure 3 Average annual increase (%) in potential gains in 
life expectancy due to obesity in 26 European countries and 
the USA between 1975 and 2012, in men. 
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Table 1 shows the impact of obesity on time trends in life 
expectancy at birth (e0). Overall, the average increase in 
e0 between 1975 and 2012 was 7.26 years for men and 6.28 
years for women in the 26 European countries. Without 
obesity, the average increase in e0 would have been 8.04 
years for men and 6.58 years for women, or 0.78 and 0.30 
years higher, respectively. Among men, obesity had the 
greatest impact on e0 trends in Lithuania and the USA 
(more than 1 year), and the smallest impact in Iceland 
and Sweden (0.5 years). Among women, obesity had the 
greatest impact on e0 trends in the USA and Ireland (0.7 
years) and the smallest impact in Estonia and the Czech 
Republic (less than 0.1 year).
DIsCussIOn
summary of results
In the 26 European countries studied, the share of 
mortality due to obesity in 2012 was, on average, 11% 
among men and 10% among women. PGLE due to 
obesity in 2012 ranged from 0.86 to 1.73 years among 
men, and from 0.66 to 1.54 years among women. Overall, 
PGLE increased between 1975 and 2012, although 
more quickly among men (average annual increase: 
2.68%) than among women (1.33%). Among women 
in Denmark, Switzerland and the CEE countries, the 
increase in PGLE levelled off after 1995. Without obesity, 
the average increase in e0 between 1975 and 2012 would 
have been 0.78 years higher among men and 0.30 years 
higher among women.
evaluation of data and methods
Using the recent advances in obesity data, it is now 
possible to study the impact of obesity on life expectancy 
for a large number of countries and a long period of 
time. Two methodological issues warrant our attention, 
however.
First, in calculating the share of mortality due to obesity 
(OAMF), which also forms the basis for our PGLE calcu-
lations, we were hindered by limitations in the available 
prevalence and RRs data, which also affected the method 
used. As has previously been documented, OAMF esti-
mates are sensitive to the data and the methods used.27
In selecting obesity prevalence data, we used the longest 
validated time series based on population-based measure-
ment studies that are suitable for studying the impact 
of obesity on long-term life expectancy trends across 
Europe.13 For those countries with less available obesity 
data—especially the CEE countries—a portion of the data 
we used were merely the result of modelling. Thus, the 
resulting estimates should be treated with some caution. 
By contrast, for the non-CEE countries, most of the data 
we used pertain to measured data.13 Online supplemen-
tary table S3 gives the confidence intervals around the 
age-standardised prevalence estimates for each country 
by sex in order to provide more information on the rela-
tive reliability of the data for the different countries in 
our analysis.
Because age-specific and sex-specific RRs of mortality 
associated with obesity are not readily available by 
country and year, we have decided to apply to all of the 
countries studied age-specific and sex-specific RRs from 
Western European and US populations that are largely 
suitable for our setting, as had previously been done.10 
Although RRs could differ slightly across contexts, 
studies that compared RRs across continents found only 
small differences in RRs between Europe and North 
America.7 Consequently, we do not expect to observe 
large differences between individual countries. In addi-
tion, as time-variant European RRs were not available, 
we had to apply time-constant RRs, even though it is 
possible that changes in the association of obesity with 
mortality—which could, for example, occur because of 
improvements in the treatment of chronic diseases—
have affected the impact of obesity on life expectancy. 
Previous studies that assessed changes over time in the 
association of obesity with mortality did so only for the 
USA, and unfortunately provided mixed evidence, with 
some of these studies reporting a decline18 28 29 and others 
finding an increase.30 Therefore, before implementing 
time-variant European RRs, more information on their 
direction is required. Similarly, comparable country-spe-
cific RRs are urgently needed. In addition, the choice 
of these RRs along with their reference group might 
exert an effect on our estimates. Based on the available 
data, only a fairly simple method—although commonly 
applied namely the weighted sum method could be 
applied27 to estimate the OAMFs. The application of a 
more advanced methodology27 could have affected the 
OAMFs and thus the PGLE levels, but less the trends.31 
The lack of information on the uncertainty of the RRs 
we used limited us in estimating CIs for the OAMFs and 
PGLEs.
Second, besides being the result of the OAMFs, PGLE 
estimates can also be affected by all-cause mortality 
levels and trends as age-specific and sex-specific all-cause 
mortality rates are used to estimate PGLE. Since all-cause 
mortality fluctuated greatly in CEE in the analysed 
period,12 short-term variations in PGLE in CEE countries 
should be treated with more caution.
Figure 4 Average annual increase (%) in potential gains in 
life expectancy due to obesity in 26 European countries and 
the USA between 1975 and 2012, in women.
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explanation of results
In 2012, the PGLE due to obesity were, on average, 1.22 
years for men and 0.98 years for women in the 26 Euro-
pean countries, and 1.73 years for men and 1.43 years for 
women in the USA. A comparison of our 2006 e50 esti-
mates with those of Preston et al10 for the same countries 
uncovered only small differences, except among men in 
the USA (our estimate was 0.56 years lower) and women 
in the UK (our estimate was 0.29 years lower) (see online 
supplementary table S4). Given that approximately the 
same methodology was used to estimate the OAMFs, 
the observed differences are most likely due to the use 
of different obesity prevalence and RRs data. Preston 
et al10 used prevalence data from national representative 
surveys and RRs from the prospective studies collabora-
tion. Given that the observed differences do not have the 
same direction for the different countries, we believe that 
these differences are mainly attributable to the prevalence 
data used. To further evaluate our observed PGLE levels, 
we compared them with own PGLE estimates for smoking 
and alcohol.32 Our PGLE estimates for smoking were 2.38 
years for men and 1.00 year for women in Western Europe, 
and 3.82 years for men and 0.67 years for women in CEE. 
Our PGLE estimates for alcohol were 0.90 years for men 
and 0.44 years for women in Western Europe, and 2.15 
years for men and 1.00 year for women in CEE,32 while 
our average PGLE for obesity was 1.08 among men and 
0.86 among women in Western Europe, and 1.44 among 
men and 1.16 among women in CEE. Thus, obesity’s 
impact on life expectancy lies between that of smoking 
and alcohol, and can be considered significant.
In our study, we found that PGLE due to obesity was 
increasing, but that this trend differed across coun-
tries and between the sexes. This overall trend can be 
explained by the general increase in obesity prevalence 
in European countries (see online supplementary figure 
S3)13 and the resulting growth in the burden of obesity,3 
which is also reflected in the OAMFs (figure 1, online 
supplementary figure S1) in these countries.
At the same time, parts of the observed variation in 
the increase in PGLE estimates across the USA, Western 
Europe and CEE and between the sexes reflect differ-
ences in the onset, the development and the impact 
of the obesity epidemic in these countries and in men 
and women. Across the countries studied, the absolute 
increase in PGLE was largest among women and the 
second largest among men in the USA. This pattern is 
in line with evidence showing that between 1980 and 
2008, obesity increased much more in the USA than in 
Europe.1 33 This rapid progression of the obesity epidemic 
in the USA and its large impact on life expectancy has 
been attributed to an increasingly obesogenic environ-
ment caused by factors such as changes in food prepa-
ration and processes that promote the consumption of 
calorically dense foods, and a pronounced decrease 
in physical activity levels.34 The obesity epidemic has 
progressed more slowly in Western Europe than in the 
USA.1 13 However, obesity levels in countries like the UK 
and Ireland are rapidly approaching those in the USA,35 
as our PGLE estimates also show.
In the CEE countries, the PGLE trends track the evolu-
tion of the obesity epidemic in that region (see online 
supplementary figure S3). Obesity levels have been 
higher in CEE than in Western Europe since 1980,36 37 
which suggests that the epidemic started earlier in CEE. 
As a result of this earlier onset, the impact of obesity (as 
expressed in terms of OAMF and PGLE) in the 1970s and 
1980s was at times even greater in CEE than in the USA, 
especially among women. While there are many potential 
explanations for this early onset of the obesity epidemic 
in CEE, the available data indicate that the main factors 
were the relatively high total energy supply and energy 
intake in CEE in those years.38
The overall progress of the obesity epidemic was lower 
in CEE than in Western Europe, and the increase was 
not constant.1 Indeed, in CEE, increases in obesity prev-
alence,1 39 OAMFs and PGLE stagnated in the 1980–2008 
period, and were more pronounced in the 1990s.1 39 
However, as these countries started the study period with 
higher obesity prevalence levels, these trends resulted 
in the CEE having higher average PGLE levels than the 
West. The pattern of stagnation observed in the CEE 
could be explained by the decrease in energy supplies at 
the beginning of the 1990s in CEE,37 resulting from the 
dramatic economic and political changes in those coun-
tries,3 36 39 and which in turn affected the socioeconomic 
status (SES) of the population. Among CEE women, the 
increase in obesity starting in the 1990s was smaller than 
it was in the previous period and was smaller than it was 
among CEE men. The lower risk of obesity observed 
among women than among men with low SES in low-in-
come countries40 may explain this difference.
In Western Europe, a stagnation in PGLE levels was 
observed among women in Denmark and Switzerland 
after 1995. This finding seems to be in line with studies 
reporting a levelling off of mean BMI since the 1990s,41 
and in specific subpopulations such as adults with high 
SES in regions within Switzerland, Italy, France and 
Finland.37 Although dietary and physical activity informa-
tion is spreading equally across socioeconomic groups, 
those with higher SES have a greater ability and capacity 
to adopt a healthier dietary and physical activity pattern.42 
In addition, it appears that higher SES women in partic-
ular are more health-conscious, have healthier food 
habits and are more prone to follow nutritional recom-
mendations43 as they are under greater social pressure to 
be thin.44 Similarly, countries with higher income levels 
and lower levels of inequality,45 like Switzerland and 
Denmark, tend to have lower obesity levels, especially 
among women.
When we considered the impact of obesity on life 
expectancy in the 26 European countries, we found that 
without obesity, the increase in e0 between 1975 and 2012 
would have been, on average, 0.78 years higher among 
men and 0.30 years higher among women. These figures 
account for approximately 10% of the average change in 
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e0 between 1975 and 2012 among men and 5% among 
women. It is therefore clear that the impact of obesity 
on changes in e0 should not be ignored. Moreover, the 
impact of obesity on life expectancy levels and on life 
expectancy trends is likely to increase, as previous studies 
have also suggested.8 There are several indicators pointing 
in that direction, including evidence that obesity’s impact 
is already substantially greater in the USA (13% among 
men and 15% among women) than elsewhere; obesity 
prevalence is increasing rapidly in most European coun-
tries (see online supplementary figure S3); obesity is 
increasing in severity; and the duration of obesity is rising 
in younger generations.8
COnClusIOn AnD IMPlICAtIOns
Obesity was proven to have an impact on both life expec-
tancy levels and trends in Europe. The observed differ-
ences in the increase in the impact of obesity across 
countries and between the sexes reflect differences in 
the onset and the progression of the obesity epidemic, 
and can be linked to contextual factors (economic condi-
tions, obesogenic environment, energy supplies), as well 
as to differences in people’s ability and capacity to adopt 
healthier lifestyles.
It is likely that in the future obesity will have a larger 
impact on mortality and life expectancy in Europe, as 
obesity prevalence and obesity-attributable mortality 
continue to increase in the majority of countries. These 
trends will have important health, economic and social 
implications. Specifically, the increasing prevalence of 
obesity among European populations, and especially 
at younger ages, will lead to an increased prevalence of 
obesity-related disorders, as well as to increases in the 
mortality burden associated with obesity and in obesity’s 
effects on life expectancy and quality of life. Thus, obesity 
will constitute an additional burden for societies, econo-
mies and public health. It is therefore crucial that effec-
tive public health initiatives are undertaken to tackle the 
obesity epidemic and its effects on public health. Such 
initiatives should address the multifactorial and complex 
obesity aetiology, the clear differences between countries 
and the sexes, as well as the factors underlying these differ-
ences, such as contextual factors and differences in indi-
viduals’ ability and capacity to adopt healthier lifestyles.
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